PQA has published nearly 90 blogs this year, providing insights and updates on our work to improve medication use quality. As we close out 2022, here’s a look back at the top five blogs of the year.
PQA is dedicated to improving safe, effective and appropriate medication use and addressing issues that impact a person’s ability to access and use medications. Many of those issues are driven by inequities in our society and health care system.
This year, PQA convened its members and stakeholders to advance our work on pharmacy performance measures and oral anticancer medication (OAM) use quality. As we move into 2023, PQA will continue to drive innovative measures and quality strategies.
There are several important policy issues that could impact pharmacists’ ability to positively affect the quality of care for patients through the use of pharmacy performance measures.
PQA members are currently voting on one measure up for endorsement and four measures for retirement.
PQA will host an all-member webinar on Thursday, December 1, from 1:00-2:00 p.m. ET, to discuss the measures up for endorsement and retirement consideration.
We are excited to host members next week at the 2022 PQA Leadership Summit. This year we will explore quality and value in medication use from patient, provider, purchaser, payer and industry perspectives.
The PQA Quality Essentials Webinar series provides education on the fundamentals of quality measurement, which is important for effective measure implementation and performance, and information about where and how PQA quality measures are used.
PQA offers a variety of student and professional programs, including a Masters of Public Health (MPH) Practicum Program, which provides internship opportunities and field experience to MPH students across all public health disciplines. The program’s foundation begins with the applicant’s interests to foster skill development in health services research methods, quality measurement, research communications and diverse stakeholder engagement.
PQA’s talented staff is dedicated to improving medication safety, adherence and appropriate use. As experts in measure development, research, education and convening, they lead the implementation of PQA’s quality initiatives to support better medication use and high-quality care. This blog is one in a series profiling PQA's staff.
PQA is launching a national initiative to prioritize research and measurement strategies to improve the quality of care for individuals using oral anticancer medications (OAM).
What constitutes quality and value in medication use?
The PQA Quality Forum Webinar is a regular, recurring series on healthcare quality topics with a focus on medication use and medication services. It is a forum for educating and engaging with PQA members and quality-focused healthcare professionals.
PQA follows a systematic, transparent, and consensus-based process in the development and maintenance of measures. This process ensures that PQA measures are relevant and continue to support improvement in health care.
PQA, the Pharmacy Quality Alliance, is launching a national initiative to prioritize research and measurement strategies to improve the quality of care for individuals using oral anticancer medications (OAM).
Collaboration is one of PQA's greatest attributes, and our measure development process is the embodiment of how our diverse member organizations reach consensus on evaluating medication use quality. The public comment period is an important part of our systematic and transparent consensus-based process.
The Pharmacy Quality Alliance (PQA) has developed a new health plan performance measure focused on medication adherence, Proportion of Days Covered Composite (PDC-CMP). PQA is actively soliciting feedback on this measure via a public comment period which opened on October 3 and will close on October 24, 2022. Stakeholders are invited to provide comments.
PQA is a non-profit organization with 250 diverse members across healthcare. Our members include community and specialty pharmacy organizations, pharmacists and other healthcare providers, pharmacies, health plans, pharmacy benefit managers, life sciences, technology vendors, government agencies, health information technology partners, researchers, accrediting organizations and academia.
Social determinants of health (SDOH) are a priority for PQA because, in addition to traditional care, issues like medication cost, literacy, transportation and food security impact a person’s ability to access medications and use them safely and effectively.
PQA has appointed 15 individuals from member organizations to serve on a technical expert panel (TEP) to review and provide input on draft specification for a health plan performance measure concept: COPD (chronic obstructive pulmonary disease) Treatment Ratio (CTR).
